ArticleThe journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG2025
Survey of Diabetes Technology in the Pediatric Inpatient Setting.
Article in The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- EndoBridge 2025: pearls and highlights.Hormones (Athens, Greece) · 2026Review
- Technology in Diabetes: A Year in Review.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2026Review
- 16. Diabetes Care in the Hospital: Standards of Care in Diabetes-2026.Diabetes care · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveAdvances in diabetes technology have led to increasing use of insulin pumps and continuous glucose monitors (CGMs) to improve the quality of life for children with diabetes. The objective of this study was to assess the percentage of hospitals that had policies regarding the use of diabetes technology in the pediatric inpatient setting and assess the content of policies to identify specific areas for improvement.
methodsA diabetes technology survey was developed by a multidisciplinary research team, consisting of 3 domains including CGM use/policies, insulin pump use/policies, and demographics. It was distributed to the pharmacist membership of the Pediatric Pharmacy Association in August 2022. Descriptive statistics were conducted to describe current practices/policies.
resultsSeventeen of the 31 responding hospitals (55%) allowed CGM use in the pediatric inpatient setting with 77% (n = 13) having written policies. Primary barriers to use included lack of policy (n = 11, 79%), knowledgeable staff (n = 10, 71%), and electronic health record (EHR) integration (n = 6, 43%). More than half reported not using CGM alarms for high and low blood sugar levels (n = 10, 59%). More hospitals allowed insulin pump use (n = 29, 94%) with 97% (n = 28) reporting written policies. Less than half had specific policies for suspected pump site failure (n = 13, 46%). Only 60% reported that nurses verify insulin pump doses given.
conclusionThis study demonstrates there is room to improve both the existence and content of policies related to CGM and insulin pump use in hospitals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.